Susquehanna International Group, LLP Immunic, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.08 - $1.95 $22,356 - $40,365	20,700 Added 11.15%	206,400 $340,000
Q2 2024 Aug 15, 2024	BUY	$0.98 - $1.44 $48,706 - $71,568	49,700 Added 36.54%	185,700 $206,000
Q1 2024 May 07, 2024	BUY	$1.14 - $1.53 $26,789 - $35,955	23,500 Added 20.89%	136,000 $179,000
Q4 2023 Feb 14, 2024	BUY	$0.97 - $1.6 $12,610 - $20,800	13,000 Added 13.07%	112,500 $168,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $2.87 $19,440 - $41,328	14,400 Added 16.92%	99,500 $146,000
Q2 2023 Aug 11, 2023	SELL	$1.33 - $2.51 $98,287 - $185,488	-73,900 Reduced 46.48%	85,100 $213,000
Q1 2023 May 16, 2023	SELL	$1.35 - $2.87 $21,735 - $46,207	-16,100 Reduced 9.19%	159,000 $236,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $10.8 $185,093 - $1.77 Million	163,800 Added 1449.56%	175,100 $245,000
Q3 2022 Nov 14, 2022	SELL	$3.0 - $5.49 $26,400 - $48,312	-8,800 Reduced 43.78%	11,300 $36,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.